Technical Analysis for LUNG - Pulmonx Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 7.52 | 0.27% | 0.02 |
Earnings due: May 1
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 1,2,3 Retracement Bearish | Bearish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.27% | |
| Oversold Stochastic | Weakness | 0.27% | |
| New 52 Week Closing Low | Bearish | 1.62% | |
| MACD Bullish Signal Line Cross | Bullish | 1.62% | |
| NR7 | Range Contraction | 1.62% | |
| Narrow Range Bar | Range Contraction | 1.62% |
| Alert | Time |
|---|---|
| Up 2% | about 16 hours ago |
| Rose Above Previous Day's High | about 17 hours ago |
| 10 DMA Resistance | about 17 hours ago |
| Up 1% | about 17 hours ago |
| 60 Minute Opening Range Breakout | about 17 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/01/2024
Pulmonx Corporation Description
Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Inflation Medical Technology Catheter Chronic Obstructive Pulmonary Disease Pulmonary Disease Tomography Pulmonology Balloon Catheter Invasive Medical Devices Lung Minimally Invasive Medical Devices
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.835 |
| 52 Week Low | 7.21 |
| Average Volume | 620,358 |
| 200-Day Moving Average | 10.90 |
| 50-Day Moving Average | 9.45 |
| 20-Day Moving Average | 8.07 |
| 10-Day Moving Average | 7.60 |
| Average True Range | 0.38 |
| RSI (14) | 32.89 |
| ADX | 39.03 |
| +DI | 16.29 |
| -DI | 28.91 |
| Chandelier Exit (Long, 3 ATRs) | 8.33 |
| Chandelier Exit (Short, 3 ATRs) | 8.34 |
| Upper Bollinger Bands | 9.29 |
| Lower Bollinger Band | 6.85 |
| Percent B (%b) | 0.27 |
| BandWidth | 30.24 |
| MACD Line | -0.57 |
| MACD Signal Line | -0.60 |
| MACD Histogram | 0.0344 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.87 | ||||
| Resistance 3 (R3) | 7.88 | 7.78 | 7.81 | ||
| Resistance 2 (R2) | 7.78 | 7.69 | 7.77 | 7.79 | |
| Resistance 1 (R1) | 7.65 | 7.63 | 7.71 | 7.64 | 7.77 |
| Pivot Point | 7.54 | 7.54 | 7.57 | 7.54 | 7.54 |
| Support 1 (S1) | 7.41 | 7.45 | 7.48 | 7.40 | 7.27 |
| Support 2 (S2) | 7.31 | 7.40 | 7.30 | 7.25 | |
| Support 3 (S3) | 7.18 | 7.31 | 7.23 | ||
| Support 4 (S4) | 7.17 |
